Showing Results : 1-1 of 1
Sort By :
  • The Journal of Clinical Investigation: 2023, vol: 133, issue: 24
  • 1)- Vaidya Govindarajan, Jay Chandar, Avindra Nath, Ashish H Shah. Metagenome analyses identify human endogenous retrovirus-K113 (HML-2) subtype in glioblastoma. Reply. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 0
    Read More
  • 2)- Amanda Macamo, Jan Beckervordersandforth, Axel Zur Hausen. Metagenome analyses identify human endogenous retrovirus-K113 (HML-2) subtype in glioblastoma. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 0
    Read More
  • 3)- Sandeep K Mallipattu. The loss of profilin1 is catastrophic to podocytes. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 0
    Read More
  • 4)- Xuebin Zhang, Zengming Wang, Shengsong Huang, Dongyin He, Weiwei Yan, Qian Zhuang, Zixian Wang, Chenyang Wang, Qilong Tan, Ziqun Liu, Tao Yang, Ying Liu, Ruobing Ren, Jing Li, William Butler, Huiru Tang, Gong-Hong Wei, Xin Li, Denglong Wu, Zhenfei Li. Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 1
    Read More
  • 5)- Sean Sachdev. A friend in a forest of radiation-immune interactions: BAMBI improves antitumor effects by limiting radioresistance. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 0
    Read More
  • 6)- Liangliang Wang, Wei Si, Xianbin Yu, Andras Piffko, Xiaoyang Dou, Xingchen Ding, Jason Bugno, Kaiting Yang, Chuangyu Wen, Linda Zhang, Dapeng Chen, Xiaona Huang, Jiaai Wang, Ainhoa Arina, Sean Pitroda, Steven J Chmura, Chuan He, Hua Laura Liang, Ralph Weichselbaum. Epitranscriptional regulation of TGF-β pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 2
    Read More
  • 7)- Na Jing, Kai Zhang, Xinyu Chen, Kaiyuan Liu, Jinming Wang, Lingling Xiao, Wentian Zhang, Pengfei Ma, Penghui Xu, Chaping Cheng, Deng Wang, Huifang Zhao, Yuman He, Zhongzhong Ji, Zhixiang Xin, Yujiao Sun, Yingchao Zhang, Wei Bao, Yiming Gong, Liancheng Fan, Yiyi Ji, Guanglei Zhuang, Qi Wang, Baijun Dong, Pengcheng Zhang, Wei Xue, Wei-Qiang Gao, Helen He Zhu. ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 7
    Read More
  • 8)- Michael R Schlabach, Sharon Lin, Zachary R Collester, Christopher Wrocklage, Sol Shenker, Conor Calnan, Tianlei Xu, Hugh S Gannon, Leila J Williams, Frank Thompson, Paul R Dunbar, Robert A LaMothe, Tracy E Garrett, Nicholas Colletti, Anja F Hohmann, Noah J Tubo, Caroline P Bullock, Isabelle Le Mercier, Katri Sofjan, Jason J Merkin, Sean Keegan, Gregory V Kryukov, Caroline Dugopolski, Frank Stegmeier, Karrie Wong, Fiona A Sharp, Louise Cadzow, Micah J Benson. Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 3
    Read More
  • 9)- Deborah A Knight, Shin Foong Ngiow, Ming Li, Tiffany Parmenter, Stephen Mok, Ashley Cass, Nicole M Haynes, Kathryn Kinross, Hideo Yagita, Richard C Koya, Thomas G Graeber, Antoni Ribas, Grant A McArthur, Mark J Smyth. Host immunity contributes to the anti-melanoma activity of BRAF inhibitors. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 0
    Read More
  • 10)- Xiaobo Wang, Shuang Geng, Junchen Meng, Ning Kang, Xinyi Liu, Yanni Xu, Huiyun Lyu, Ying Xu, Xun Xu, Xinrong Song, Bin Zhang, Xin Wang, Nuerdida Nuerbulati, Ze Zhang, Di Zhai, Xin Mao, Ruya Sun, Xiaoting Wang, Ruiwu Wang, Jie Guo, S R Wayne Chen, Xuyu Zhou, Tie Xia, Hai Qi, Xiaoyu Hu, Yan Shi. Foxp3-mediated blockage of ryanodine receptor 2 underlies contact-based suppression by regulatory T cells. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 4
    Read More
  • 11)- Sean M Tatum, William L Holland. Germline and conditional ghrelin knockout increases islet size. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 1
    Read More
  • 12)- Deepali Gupta, Avi W Burstein, Dana C Schwalbe, Kripa Shankar, Salil Varshney, Omprakash Singh, Subhojit Paul, Sean B Ogden, Sherri Osborne-Lawrence, Nathan P Metzger, Corine P Richard, John N Campbell, Jeffrey M Zigman. Ghrelin deletion and conditional ghrelin cell ablation increase pancreatic islet size in mice. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 3
    Read More
  • 13)- Erienne G Norton, Nicole M Chapman, Hongbo Chi. Strengthening bonds via RyR2 inhibition helps immune suppression. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 1
    Read More
  • 14)- Nannan Zhou, Jie Chen, Zheng Ling, Chaoqi Zhang, Yabo Zhou, Dianheng Wang, Li Zhou, Zhenfeng Wang, Nan Sun, Xin Wang, Huafeng Zhang, Ke Tang, Jingwei Ma, Jiadi Lv, Bo Huang. Aryl hydrocarbon receptor sulfenylation promotes glycogenolysis and rescues cancer chemoresistance. The Journal of clinical investigation. 2023, 133 (24):
    Cited : 4
    Read More
 
 


Journal List
Links
Content Links
About Us

0